Wei Luo

Wei Luo is a Senior Scientist at Alvogen since May 2018 and has held significant roles in the pharmaceutical industry, including Senior Scientist and Principal Scientist positions at Teva Pharmaceuticals from January 2009 to May 2018, and Principal Scientist at Duramed Research, a subsidiary of Barr Pharmaceuticals, from December 2002 to December 2008. Prior experience includes serving as a Senior Scientist at Barr Pharmaceuticals from July 1998 to November 2002. Wei Luo earned a Doctor of Philosophy (PhD) in Organic Chemistry from The City University of New York.